Metabolic Tumour Volume from PSMA PET/CT Scans of Prostate Cancer Patients during Chemotherapy-Do Different Software Solutions Deliver Comparable Results?
Prostate-specific membrane antigen (PSMA)
agreement
biomarker
comparability
metabolic tumour volume (MTV)
software
total lesion PSMA
Journal
Journal of clinical medicine
ISSN: 2077-0383
Titre abrégé: J Clin Med
Pays: Switzerland
ID NLM: 101606588
Informations de publication
Date de publication:
08 May 2020
08 May 2020
Historique:
received:
12
03
2020
revised:
04
05
2020
accepted:
06
05
2020
entrez:
14
5
2020
pubmed:
14
5
2020
medline:
14
5
2020
Statut:
epublish
Résumé
(1) Background: Prostate-specific membrane antigen (PSMA)-derived tumour volume (PSMA-TV) and total lesion PSMA (TL-PSMA) from PSMA PET/CT scans are promising biomarkers for assessing treatment response in prostate cancer (PCa). Currently, it is unclear whether different software tools for assessing PSMA-TV and TL-PSMA produce comparable results. (2) Methods:
Identifiants
pubmed: 32397223
pii: jcm9051390
doi: 10.3390/jcm9051390
pmc: PMC7290891
pii:
doi:
Types de publication
Journal Article
Langues
eng
Déclaration de conflit d'intérêts
The authors declare no conflict of interest.
Références
Eur J Nucl Med Mol Imaging. 2018 Apr;45(4):602-612
pubmed: 29185010
J Nucl Med Technol. 2020 Mar;48(1):30-35
pubmed: 31604902
J Nucl Med. 2012 May;53(5):709-15
pubmed: 22492732
J Nucl Med. 2017 Dec;58(12):1962-1968
pubmed: 28522740
J Nucl Med. 2018 Mar;59(3):469-478
pubmed: 29123012
Cancers (Basel). 2019 May 23;11(5):
pubmed: 31126127
J Nucl Med. 2018 Jul;59(7):1070-1075
pubmed: 29242401
Ann Nucl Med. 2019 May;33(5):344-350
pubmed: 30746599
J Nucl Med. 2019 Sep;60(9):1277-1283
pubmed: 30850484
J Natl Cancer Inst. 2000 Feb 2;92(3):205-16
pubmed: 10655437
Eur J Nucl Med Mol Imaging. 2018 Oct;45(11):1862-1872
pubmed: 29725716
PLoS One. 2015 Oct 16;10(10):e0140830
pubmed: 26473950
Lancet. 1986 Feb 8;1(8476):307-10
pubmed: 2868172
Behav Res Methods. 2009 Nov;41(4):1149-60
pubmed: 19897823
Ann Nucl Med. 2019 Sep;33(9):681-688
pubmed: 31214958
Cancers (Basel). 2019 Dec 20;12(1):
pubmed: 31861942
J Nucl Med. 2020 Jan 10;:
pubmed: 31924729
J Nucl Med. 2012 Oct;53(10):1506-13
pubmed: 22895812
Nat Methods. 2012 Jun 28;9(7):676-82
pubmed: 22743772
Urol Ann. 2019 Apr-Jun;11(2):155-162
pubmed: 31040600
J Nucl Med. 2009 May;50 Suppl 1:122S-50S
pubmed: 19403881
Nucl Med Mol Imaging. 2018 Dec;52(6):420-429
pubmed: 30538773
Gynecol Oncol. 2011 Feb;120(2):270-4
pubmed: 21109300
J Nucl Med. 2014 Jun;55(6):898-904
pubmed: 24711649